Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

Background: Care gaps remain in modern health care despite the availability of robust, evidence-based medications. Although sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated profound benefits in improving both cardiovascular and kidney outcomes in patients, the uptake of these medi...

Full description

Bibliographic Details
Main Authors: Tae Won Yi, Daniel V. O’Hara, Brendan Smyth, Meg J. Jardine, Adeera Levin, Rachael L. Morton
Format: Article
Language:English
Published: SAGE Publishing 2024-01-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/20543581231217857

Internet

https://doi.org/10.1177/20543581231217857

Similar Items